Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11522619.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The presence of coxsackie and adenovirus receptor (CAR) and alpha(v) integrin on cell surfaces is required for efficient adenovirus infection. Treatment of cells with the histone deacetylase inhibitor FR901228 (depsipeptide) increased CAR and alpha(v) integrin RNA levels in six cancer cell lines. Sodium butyrate and trichostatin A, other histone deacetylase inhibitors, caused similar increases. Cells treated with FR901228 prior to infection had a 4-10-fold increase in transgene expression from a beta-galactosidase-expressing adenoviral vector. These studies suggest that FR901228 increases the efficiency of adenoviral transgene expression and may be useful in cancer gene therapy.
Medical subject headings
- Adenoviridae
- Anti-Bacterial Agents
- Antigens, CD
- Depsipeptides
- Enzyme Inhibitors
- Histone Deacetylase Inhibitors
- Peptides, Cyclic
- Receptors, Virus
- Transgenes